Pfizer Inc. CEO Ian Read used his speech at the National Press Club to push for an old idea – a transferable exclusivity voucher program to incentivize antibiotic development.
Antibiotic Incentives: Pfizer’s Read Touts Exclusivity Voucher
Providing a transferable period of patent-life extension in exchange for US FDA approval of a new antibiotic would incentivize ‘the whole ecosystem’ to find new treatments for emerging diseases, CEO Ian Read says.
